Stereotaxis wins CE mark for Synchrony system, submits to FDA
Stereotaxis Receives CE Mark and Submits Synchrony System to FDA Stereotaxis (NYSE:STXS) announced that it has received CE mark for its Synchrony system and submitted it to the FDA.
Stereotaxis Receives CE Mark and Submits Synchrony System to FDA Stereotaxis (NYSE:STXS) announced that it has received CE mark for its Synchrony system and submitted it to the FDA.
Latest Developments in Telecom Broadcom is leading the charge on Wi-Fi 8. Bell Canada has unveiled a new three-year strategy.
Jamaica Bounce Back to Topple Bermuda Jamaica are in charge of their own destiny in the final round of CONCACAF World Cup qualifiers, foll…
Alan Jackson's Final Show: Last Call Country legend Alan Jackson has announced his final concert, Last Call: One More For The Road – Th…
Cambridge Residents' Concerns About Upzoning One candidate notes that residents are having second thoughts about the implementation of mul…
Warburtons Expands Production with Roberts Bakery Site Acquisition Warburtons has acquired the specialty bread factory of Roberts Bakery i…
Goldbug Governor: Ron DeSantis Blames Fed for Metal Valuation Surge Ron DeSantis isn't surprised by the surge in gold and silver values, a…
Love's Labour's Lost: Exploring Commitment Shakespeare's comedy "Love's Labour's Lost" provides a humorous exploration of how differently …
Americans Aim for Individual Honors at 2025 FIG Artistic World Championships Ten Americans, with nine Worlds medals between them, are prep…
Arbitrary Thoughts: Royce Lewis The Twins' former 1st overall pick played in more than 100 games in 2025. Did he do enough to solidify a p…
Pharmacists' Role in Arrhythmia Care Lindsey Valenzuela, PharmD, highlights the importance of pharmacists in value-based care models for m…